Stanislaw R Burzynski, M.D
FDA inspection history in Houston, Maryland, 2013
- 1
- Form 483
Every document, by year
- Form 483
2013: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2013One Form 483, at Houston, Maryland.
Cited most
Across all Stanislaw R Burzynski, M.D observations on file
- 21 CFR 312.62(a)Investigator recordkeeping and record retention2
- 21 CFR 312.60General responsibilities of investigators1
- 21 CFR 312.66Assurance of IRB review1
- 21 CFR 50.20General requirements for informed consent1
- 21 CFR 50.23Exception from general requirements1
The complete Stanislaw R Burzynski, M.D file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Houston, Maryland
One Form 483 · 2013 · 6 observations
Latest: Form 483, Mar 15, 2013 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2013-03-15 | 483 Form 483 | Houston, Maryland | 6 | $99 |
Investigators on these documents
Cynthia F. Kleppinger (1)Hugh M. McClure (1)Joel Martinez (1)
FEI number 3003426453 · most recent document Mar 15, 2013
About Stanislaw R Burzynski, M.D
How many FDA Form 483s has Stanislaw R Burzynski, M.D received?
FDA Intel has 1 Form 483 on file for Stanislaw R Burzynski, M.D; the most recent is dated Mar 15, 2013.
When was Stanislaw R Burzynski, M.D last inspected by FDA?
The most recent FDA inspection document on file for Stanislaw R Burzynski, M.D is a Form 483 dated Mar 15, 2013, for the site in Houston, Maryland.
What did FDA cite at Stanislaw R Burzynski, M.D?
The regulations cited most in the observations on file for Stanislaw R Burzynski, M.D are 21 CFR 312.62(a) (Investigator recordkeeping and record retention), 2 times; 21 CFR 312.60 (General responsibilities of investigators), 1 time; 21 CFR 312.66 (Assurance of IRB review), 1 time.